Literature DB >> 18478669

Experts' agency problems: evidence from the prescription drug market in Japan.

Toshiaki Iizuka.   

Abstract

This article examined the physician-patient agency relationship in the context of the prescription drug market in Japan. In this market, physicians often both prescribe and dispense drugs and can pocket profits in so doing. A concern is that, due to the incentive created by the mark-up, physicians' prescription decisions may be distorted. Empirical results using anti-hypertensive drugs suggest that physicians' prescription choices are influenced by the mark-up. However, physicians are also sensitive to the patient's out-of-pocket costs. Overall, although the mark-up affects prescription choices, physicians appear more responsive to the patient's out-of-pocket costs than their own profits from mark-up.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18478669     DOI: 10.1111/j.0741-6261.2007.00115.x

Source DB:  PubMed          Journal:  Rand J Econ        ISSN: 0741-6261


  18 in total

1.  Regulated medical fee schedule of the Japanese health care system.

Authors:  Makoto Kakinaka; Ryuta Ray Kato
Journal:  Int J Health Care Finance Econ       Date:  2013-09-26

2.  Physician response to financial incentives when choosing drugs to treat breast cancer.

Authors:  Andrew J Epstein; Scott J Johnson
Journal:  Int J Health Care Finance Econ       Date:  2012-11-03

Review 3.  Governance mechanisms in the physician-patient relationship: a literature review and conceptual framework.

Authors:  Gabriela Tofan; Virginia Bodolica; Martin Spraggon
Journal:  Health Expect       Date:  2012-08-10       Impact factor: 3.377

4.  Generic substitution, financial interests, and imperfect agency.

Authors:  Maurus Rischatsch; Maria Trottmann; Peter Zweifel
Journal:  Int J Health Care Finance Econ       Date:  2013-03-14

5.  Understanding profit margins of medical providers from prescription drugs: evidence from Taiwan.

Authors:  Ya-Ming Liu
Journal:  Int Health       Date:  2020-07-01       Impact factor: 2.473

6.  The impact of health insurance expansion on physician treatment choice: Medicare Part D and physician prescribing.

Authors:  Tianyan Hu; Sandra L Decker; Shin-Yi Chou
Journal:  Int J Health Econ Manag       Date:  2017-02-06

7.  Addressing Antibiotic Abuse in China: An Experimental Audit Study.

Authors:  Janet Currie; Wanchuan Lin; Juanjuan Meng
Journal:  J Dev Econ       Date:  2014-09-01

8.  Patient Copayments, Provider Incentives and Income Effects: Theory and Evidence from the Essential Medications List under China's 2009 Healthcare Reform.

Authors:  Brian K Chen; Y Tony Yang; Karen Eggleston
Journal:  World Med Health Policy       Date:  2017-03-16

9.  Are prescribing doctors sensitive to the price that their patients have to pay in the Spanish National Health System?

Authors:  Beatriz González López-Valcárcel; Julián Librero; Gabriel Sanfélix-Gimeno; Salvador Peiró
Journal:  BMC Health Serv Res       Date:  2011-12-08       Impact factor: 2.655

10.  Adherence and rehospitalizations in patients with schizophrenia: evidence from Japanese claims data.

Authors:  Hiroyo Kuwabara; Yoshimichi Saito; Jörg Mahlich
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-01       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.